Search

everythinglearnresearchcommunity

for

Search:↓

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Shift nurses show altered body temperature and stress hormone levels, suggesting their body clocks adjust to irregular schedules.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Skin aging is largely due to differences in stiffness and elasticity between skin layers, leading to wrinkles.

Some hair loss disorders are caused by genetic mutations affecting hair growth.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

The most common causes of hair loss in children in South-East Nigeria are fungal infections and alopecia areata.

SJS/TEN survivors often have severe, overlooked long-term physical problems that are not properly treated after leaving the hospital.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

New hair and skin changes were found in a rare case of syphilis-related hair loss.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

The document concludes that early diagnosis and treatment are crucial for children with hair loss to prevent permanent damage, although not all conditions can be effectively treated.

Most hair loss in children is caused by a few common conditions, and it's important to diagnose these properly and support the child's mental health.